| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,805,000 | 1,653,000 | 2,371,000 | 3,610,000 | | Cost of Revenue | 1,136,000 | 1,935,000 | 1,211,000 | 1,778,000 | | | Gross Profit | 669,000 | (282,000) | 1,160,000 | 1,832,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 368,000 | (398,000) | 537,000 | 452,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 120,000 | 17,000 | 206,000 | 514,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 181,000 | 99,000 | 417,000 | 866,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 | (8,000) | 19,000 | (1,000) | | Earnings Before Interest And Taxes | 190,000 | 91,000 | 436,000 | 865,000 | | Interest Expense | 106,000 | 99,000 | 89,000 | 223,000 | | Income Before Tax | 84,000 | (8,000) | 347,000 | 642,000 | | Income Tax Expense | 34,000 | (34,000) | 101,000 | 218,000 | | Minority Interest | (6,000) | (9,000) |
-
| (19,000) | | | | Net Income From Continuing Ops | 44,000 | 17,000 | 246,000 | 405,000 | | | Non-recurring Events | | Discontinued Operations | (24,000) | (29,000) |
-
| 3,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,000 | (12,000) | 246,000 | 408,000 | | Preferred Stock And Other Adjustments |
-
| 5,000 | (5,000) |
-
| | | Net Income Applicable To Common Shares | $20,000 | ($7,000) | $241,000 | $408,000 |
|
2.03% Nasdaq 0.00%
Income Statement
